Literature DB >> 7739502

Therapy for multiple sclerosis.

H L Weiner1, M J Hohol, S J Khoury, D M Dawson, D A Hafler.   

Abstract

Multiple sclerosis is hypothesized to be a cell-mediated autoimmune disease directed against central nervous system myelin. Immunotherapy is directed at decreasing the autoimmune response using both specific and nonspecific modulation of the immune system in an attempt to halt accumulation of disability. Symptomatic therapy may also help multiple sclerosis patients.

Entities:  

Mesh:

Year:  1995        PMID: 7739502

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  2 in total

Review 1.  Outcomes assessment of drug treatment in multiple sclerosis clinical trials.

Authors:  M Malone; B Lomaestro
Journal:  Pharmacoeconomics       Date:  1996-03       Impact factor: 4.981

2.  Safety profile of copolymer 1: analysis of cumulative experience in the United States and Israel.

Authors:  A D Korczyn; P Nisipeanu
Journal:  J Neurol       Date:  1996-04       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.